At present, there is no discernible evidence of a cross-cutting or all-of-government strategy to increase the commercial dividends from the scientific capital we have accumulated in the biological sciences.
A 2017 report from Deloitte and BIOTECanada found 59 per cent of the companies said they were looking to government as their first source of future financing—the vast majority of such government funding comes through Innovation, Science, and Economic Development Canada, which is overseen by Navdeep Bains, pictured, as minister. The Hill Times photograph by Andrew Meade
TORONTO—Canada is rich in the scientific capital needed to make us a serious player in the transformative world of biotechnology.
People. Policy. Politics. This is an exclusive subscriber-only story.
In a time of great uncertainty and anxiety, Dr. Theresa Tam has emerged as a 'compelling' figure who has an ability to deliver information without dramatizing the stakes. 'She gives us straightforward, evidence-based
The 'biggest point of concern right now' is 'making sure that we keep those shipments of fresh vegetables and other commodities rolling in by truck across the border, truck or train,' says John Manley.
The number of lobbying files connected to COVID-19 has exploded in the last week, with 90 registrations for 55 organizations outlining plans to push federal officials on issues ranging from policy to funding.